Clinical and pathological features of breast disease in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancer
about
The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferationPTEN deficiency: a role in mammary carcinogenesis.Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?Male breast cancer in Cowden syndrome patients with germline PTEN mutationsMyoid hamartoma of the breast with focal chondromyoxid metaplasia and pseudoangiomatous stromal hyperplasia: A case report.Exploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models.Allele-specific tumor spectrum in pten knockin miceGenes implicated in hereditary breast cancer syndromes.Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models.Translational advances regarding hereditary breast cancer syndromes.Phenotypic findings of Cowden syndrome and Bannayan-Zonana syndrome in a family associated with a single germline mutation in PTENGenetics of skin appendage neoplasms and related syndromes.Challenges in the management of a patient with Cowden syndrome: case report and literature reviewStoriform collagenoma as a clue for Cowden disease or PTEN hamartoma tumour syndrome.The hamartomatous polyposis syndromes: a clinical and molecular review.PTEN, more than the AKT pathway.Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.Validation of transgenic models of breast cancer: ductal carcinoma in situ (DCIS) and Brca1-mutation-related breast cancer.The gene dosage of class Ia PI3K dictates the development of PTEN hamartoma tumor syndrome.Novel inhibitors of the PI3K family.Common breast cancer risk variants in the post-COGS era: a comprehensive review.Phenotype-genotype correlation in familial breast cancer.Multiple primary cancers as a guide to heritability.Cowden syndrome: recognizing and managing a not-so-rare hereditary cancer syndrome.Breast hamartomas: clinicopathological and immunohistochemical studies of 24 cases.Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer.Acute-onset cerebellar symptoms in Lhermitte-Duclos disease: case report.Cowden syndrome: mucocutaneous lesions as precursors of internal malignancy.Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome.The clinical consequences of hemizygosity across 2 MB of 10q23 are restricted to Cowden syndrome.Sclerotic fibroma (storiform collagenoma)-like stroma in a fibroadenoma of axillary accessory breast tissue.Inherited predisposition to endometrial cancer: Moving beyond Lynch syndromePTENHamartoma Tumor Syndrome
P2860
Q24678674-8FA6D88E-7F4E-4F79-ADDA-6FD165472485Q24801835-BE65A395-6E49-4B9E-92EA-E71AC84FB894Q28085485-966AB28B-EA6A-40A8-BB8E-D2469CCBE642Q28359884-F53AE6FE-9162-499D-81FC-CF99B88A4A7AQ30416540-EA54F7CF-00B5-450A-B0B8-04DB8D7A965CQ33533301-D1216EFC-C741-4846-B6DA-D064C3A894FFQ33740171-C0EFC2D9-035E-47F8-ABEE-CBE5841F9D00Q33915583-CF95B04C-B286-4D8F-B372-D62C76689568Q34173563-721EADD8-444B-4C2F-B134-990CB1517583Q34229795-3290893A-AD9C-439D-99F0-84500053D651Q34263162-4AB32817-74B2-4906-B272-13C93633FB53Q35432463-E1F4F8F5-5412-45CC-9F78-FB0B93DA06CBQ35447362-C02B26A2-D881-4737-A5FE-E0230B9AA4C5Q35953604-90830879-CF9F-4E41-8B82-9F8D2C45E0BEQ36017160-7E06915B-141F-43DE-BC11-FD7BF5EE26E8Q36018533-C41F342E-D91E-4087-8126-7BA57235858EQ36753139-351221B4-12D4-4376-A89F-009A652820A9Q36843211-82D03E24-D43C-4B9C-B7D4-AE645C90F8A1Q37412593-0822FC29-7E37-4310-907D-B0F55BC83494Q37521382-EC8077C7-7EAC-4FB2-8CFB-64B81685C520Q37546115-6A547AEC-A5E1-47DF-8AD9-9DF23F2863D9Q37690575-33BB3463-309B-406A-B14B-AA99109E5E30Q37852615-835BE662-1593-4B23-92AD-7395AA8815AAQ38221583-E30D3878-28B7-45B1-9B09-6D3C048A1677Q38240785-ECD90A07-6A96-4DB8-8002-069DE1BDEA8DQ44066352-BCE80C66-8FD5-4CBE-AE02-F8DD1A1DA4F4Q44173483-EE15AE05-88F5-4892-9627-5FE824B76D2FQ46556329-0EDFDDC7-E992-437C-9DEB-79BB0E00C461Q47890517-8BD2CE7E-DB55-4D84-82AC-62E13EB6E1E2Q51155217-5C8989CF-27ED-4399-93B3-42F83ACFDC9BQ51298108-4BF0B5B0-D42D-4F56-91C6-0E4C61F3DDB4Q51324972-812FFCA1-B6B9-4CBE-B498-D054C0B2FF0AQ54996503-90282157-93E6-4066-85D9-6F6E2208D1F7Q57590810-60B7720D-7ECF-4EBE-B80B-9C8DD0D04BFF
P2860
Clinical and pathological features of breast disease in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancer
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Clinical and pathological feat ...... ncreased risk of breast cancer
@ast
Clinical and pathological feat ...... ncreased risk of breast cancer
@en
Clinical and pathological feat ...... ncreased risk of breast cancer
@nl
type
label
Clinical and pathological feat ...... ncreased risk of breast cancer
@ast
Clinical and pathological feat ...... ncreased risk of breast cancer
@en
Clinical and pathological feat ...... ncreased risk of breast cancer
@nl
prefLabel
Clinical and pathological feat ...... ncreased risk of breast cancer
@ast
Clinical and pathological feat ...... ncreased risk of breast cancer
@en
Clinical and pathological feat ...... ncreased risk of breast cancer
@nl
P2093
P1433
P1476
Clinical and pathological feat ...... ncreased risk of breast cancer
@en
P2093
A C Gruener
C A Schrager
D Schneider
M Peacocke
P356
10.1016/S0046-8177(98)90389-6
P407
P577
1998-01-01T00:00:00Z